肺腺癌中的甲素L:通过多个OMIC视角的预后意义和免疫治疗反应

Jianming Lu1, Jiaqi Liang2, Gang Xiao1,3

  • 1Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.

Cancer informatics
|December 17, 2024
PubMed
概括

甲素L (CTSL) 是肺腺癌 (LUAD) 的一个有前途的预后生物标志物. 高CTSL表达与晚期疾病和低生存率相关,表明其作为治疗点的潜力.